Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial.
| Autor: | Schröder, L., Rack, B., Sommer, H., Koch, J. G., Weissenbacher, T., Janni, W., Schneeweiss, A., Rezai, M., Lorenz, R., Jäger, B., Schramm, A., Häberle, L., Fasching, P. A., Friedl, T. W. P., Beckmann, M. W., Scholz, C. |
|---|---|
| Zdroj: | Geburtshilfe und Frauenheilkunde; 2016, Vol. 76 Issue 5, p542-550, 9p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|